Autacoid Receptors
Table of Contents
- Introduction
- Major Autacoid Receptor Families & Mechanisms
- Relevance (Dental & Maxillofacial Context)
- Related Concepts
Introduction
- Concept: A heterogeneous group of cell-surface and intracellular receptors that bind Autacoids ("local hormones" synthesized on-demand by local tissues). This family includes receptors for Histamine (
), Eicosanoids (Prostaglandins, Thromboxanes, Leukotrienes), Serotonin ( ), and Kinins (Bradykinin ). They act locally to regulate inflammation, pain signaling, vascular permeability, and smooth muscle tone. - The Analogy:
- Tech/CS: Localized Sensor Nodes & Emergency Micro-Alert Handlers.
- Explanation: Unlike systemic hormones broadcast from a central server (endocrine glands) across the global network, Autacoids are short-range local debug scripts generated right at the site of hardware damage or thermal stress. Autacoid receptors act as localized incident response terminals. When local tissue is injured, neighboring cells synthesize and dump short-lived signal packets (Histamine, Prostaglandins, Bradykinin) into the immediate extracellular space, triggering localized alerts (vasodilation, swelling, hyperalgesia) without disturbing global system operations unless the alert escalates (Anaphylaxis).
- Key Details:
- Paracrine/Autocrine Kinetics: Autacoids possess extremely short biological half-lives and exert effects close to their site of synthesis.
- Primary Functional Roles: Mediating allergic reactions, inflammatory cascades, nociception, and vascular autoregulation.
Major Autacoid Receptor Families & Mechanisms
| Autacoid Class | Key Receptor Subtypes | Primary G-Protein / Mechanism | Physiological & Pathological Effects |
|---|---|---|---|
| Histamine | Smooth muscle contraction (bronchospasm), vascular permeability, triple response of Lewis, itching. Gastric parietal acid secretion, cardiac acceleration. |
||
| Prostanoids | Nociceptor sensitization, fever induction, gastric mucosal protection, renal vasodilation. Potent vasodilation, inhibition of platelet aggregation. Potent vasoconstriction, platelet aggregation stimulation. |
||
| Leukotrienes | Intense bronchoconstriction, airway mucus hypersecretion, microvascular leakage. | ||
| Serotonin | GPCRs (except |
Cerebral vasoconstriction ( |
|
| Kinins | Chronic inflammatory pain, leukocyte recruitment. Acute pain activation, intense endothelial nitric oxide vasodilation, angioedema. |
Relevance (Dental & Maxillofacial Context)
1. Odontogenic Pain & NSAID Target Mechanisms
- Pathophysiology: Pulpal tissue damage or surgical trauma triggers Phospholipase
to release arachidonic acid, converted by COX-2 into Prostaglandin ( ). binds receptors on trigeminal nociceptors, lowering the threshold for pain activation (hyperalgesia). - Analgesic Intervention: NSAIDs (e.g., Ibuprofen) inhibit COX enzymes, eliminating
production to prevent nociceptor sensitizing cascades following extractions or endodontic therapy.
2. Histaminergic Operatory Emergencies
- Allergic Cascades: Exposure to dental allergens (e.g., Latex, Penicillins, or Acrylic resins) triggers IgE-mediated mast cell degranulation.
Activation: Histamine binds receptors on capillary endothelial cells, driving rapid fluid extravasation, acute facial urticaria, lip/tongue angioedema, and bronchospasm during anaphylaxis.
3. ACE-Inhibitor Induced Bradykinin Angioedema
- Mechanics: Angiotensin-Converting Enzyme (ACE) breaks down bradykinin. In patients taking ACE inhibitors (e.g., Lisinopril), minor mechanical trauma during dental procedures can trigger localized bradykinin accumulation.
Activation: Bradykinin activates vascular receptors, causing massive, non-pruritic swelling of the lips, tongue, and floor of the mouth that does not respond to epinephrine or steroids.
Related Concepts
- Urticaria (Histamine
-mediated cutaneous reaction) - Angioedema (Deep tissue vascular leak driven by histamine or bradykinin
receptors) - Histamine (The prototype autacoid chemical mediator)
- Chronic Spontaneous Urticaria (CSU) (Condition driven by chronic autacoid release)